{"name":"Apsen Farmaceutica S.A.","slug":"apsen-farmaceutica-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"APSTZD 3","genericName":"APSTZD 3","slug":"apstzd-3","indication":"Other","status":"phase_2"},{"name":"APSTZD 1","genericName":"APSTZD 1","slug":"apstzd-1","indication":"Other","status":"phase_2"},{"name":"APSTZD 2","genericName":"APSTZD 2","slug":"apstzd-2","indication":"Other","status":"phase_2"},{"name":"APSTZD 4","genericName":"APSTZD 4","slug":"apstzd-4","indication":"Other","status":"phase_2"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"Ibuvix® - ibuprofen","genericName":"Ibuvix® - ibuprofen","slug":"ibuvix-ibuprofen","indication":"Pain management","status":"phase_2"},{"name":"Toragesic®","genericName":"Toragesic®","slug":"toragesic","indication":"Relief of moderate to severe pain","status":"phase_3"},{"name":"Tramal®","genericName":"Tramal®","slug":"tramal","indication":"Moderate pain","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"APSCTC","genericName":"APSCTC","slug":"apsctc","indication":"Treatment of type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"APSTZD 3","genericName":"APSTZD 3","slug":"apstzd-3","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ibuvix® - ibuprofen","genericName":"Ibuvix® - ibuprofen","slug":"ibuvix-ibuprofen","phase":"phase_2","mechanism":"Inhibits COX-2 enzyme","indications":["Pain management","Inflammation","Fever"],"catalyst":""},{"name":"Toragesic®","genericName":"Toragesic®","slug":"toragesic","phase":"phase_3","mechanism":"Toragesic is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting prostaglandin synthesis.","indications":["Relief of moderate to severe pain"],"catalyst":""},{"name":"APSCTC","genericName":"APSCTC","slug":"apsctc","phase":"phase_3","mechanism":"APSCTC is a small molecule that acts as a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2).","indications":["Treatment of type 2 diabetes"],"catalyst":""},{"name":"APSTZD 1","genericName":"APSTZD 1","slug":"apstzd-1","phase":"phase_2","mechanism":"APSTZD 1 is an investigational drug with unknown mechanism of action.","indications":[],"catalyst":""},{"name":"APSTZD 2","genericName":"APSTZD 2","slug":"apstzd-2","phase":"phase_2","mechanism":"APSTZD 2 is an investigational drug with unknown mechanism of action.","indications":[],"catalyst":""},{"name":"APSTZD 4","genericName":"APSTZD 4","slug":"apstzd-4","phase":"phase_2","mechanism":"APSTZD 4 is an investigational drug with an unknown mechanism of action.","indications":[],"catalyst":""},{"name":"Tramal®","genericName":"Tramal®","slug":"tramal","phase":"marketed","mechanism":"Tramadol is a synthetic opioid analgesic that binds to mu opioid receptors and inhibits the reuptake of norepinephrine and serotonin to provide pain relief.","indications":["Moderate pain","Postoperative pain","Chronic pain conditions"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":8,"phaseCounts":{"phase_2":5,"phase_3":2,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}